Energy sector companies like Valero and Marathon Petroleum could benefit from Venezuelan oil trade tariffs.
From Nasdaq: 2025-03-30 07:15:00
The energy sector faces trade tariffs affecting Venezuelan oil, creating opportunities for companies like Valero and Marathon Petroleum. Cummins Inc. could see a 37.5% rally as tariffs potentially lead to increased demand for its diesel engines. Institutional investors are betting big on these stocks, indicating potential growth.
Valero Energy looks undervalued with a P/E ratio of 15.8x compared to the sector average of 47.3x. Recent tariff announcements could boost earnings from refining heavy oil. Institutional capital inflows of up to $2.6 billion show confidence in Valero’s future prospects.
Marathon Petroleum’s stock trading at a discount presents a favorable risk-to-reward ratio. Analysts forecast significant EPS growth for the company, potentially reaching $2.74 from the current $0.77 EPS. Wells Fargo maintains an Overweight rating with a price target of $185 per share, suggesting a 23.5% upside.
Analysts see potential gains for companies like Valero and Marathon Petroleum due to diesel bottleneck opportunities. Investors should consider the bullish thesis on diesel refiners and prices as trade tariffs create favorable conditions for these companies. 1. The stock market plunged today with the Dow Jones dropping 500 points due to rising inflation fears and concerns over a potential interest rate hike by the Federal Reserve. The S&P 500 and Nasdaq also saw significant losses, with tech stocks being hit the hardest.
2. In other news, the latest unemployment figures show a decrease in jobless claims, signaling a strengthening labor market. The number of Americans filing for unemployment benefits fell to a seasonally adjusted 320,000 last week, the lowest level since the start of the pandemic.
3. A new study reveals that the average global temperature has risen by 1.2 degrees Celsius above pre-industrial levels, reaching a critical milestone in climate change. Scientists warn that urgent action is needed to curb greenhouse gas emissions and prevent further warming of the planet.
4. The FDA has approved a new drug for the treatment of Alzheimer’s disease, marking a breakthrough in the fight against the debilitating condition. The drug, called Aduhelm, has shown promising results in clinical trials and is expected to provide much-needed relief for patients and their families.
Read more at Nasdaq:: Venezuelan Tariffs Could Power These 3 Diesel-Driven Winners